Merck & Co Inc
XETRA:6MK
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
M
|
Merck & Co Inc
XETRA:6MK
|
US |
|
Oppenheimer Holdings Inc
NYSE:OPY
|
US |
|
GOME Retail Holdings Ltd
HKEX:493
|
CN |
|
Fixstars Corp
TSE:3687
|
JP |
|
AXT Inc
NASDAQ:AXTI
|
US |
|
P
|
Pickles Holdings Co Ltd
TSE:2935
|
JP |
|
M
|
Medical Facilities Corp
TSX:DR
|
CA |
Wall Street
Price Targets
6MK Price Targets Summary
Merck & Co Inc
According to Wall Street analysts, the average 1-year price target for
6MK
is 108.2 EUR
with a low forecast of 81.06 EUR and a high forecast of 133.05 EUR.
Price Targets
Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What is available on other sites you are seeing are mostly from the sell-side analysts.
What is 6MK's stock price target?
Price Target
108.2
EUR
According to Wall Street analysts, the average 1-year price target for
6MK
is 108.2 EUR
with a low forecast of 81.06 EUR and a high forecast of 133.05 EUR.
What is Merck & Co Inc's Revenue forecast?
Projected CAGR
5%
For the last 14 years the
compound annual growth rate for
Merck & Co Inc's revenue is
2%.
The projected
CAGR
for the next 3 years is
5%.
What is Merck & Co Inc's Operating Income forecast?
Projected CAGR
6%
For the last 14 years the
compound annual growth rate for
Merck & Co Inc's operating income is
7%.
The projected
CAGR
for the next 3 years is
6%.
What is Merck & Co Inc's Net Income forecast?
Projected CAGR
14%
For the last 14 years the
compound annual growth rate for
Merck & Co Inc's net income is
8%.
The projected
CAGR
for the next 3 years is
14%.
